General Information of Drug (ID: DMKEY9V)

Drug Name
2-(3-(naphthalen-2-yl)propanamido)benzoic acid
Synonyms
CHEMBL235740; SCHEMBL5623042; BDBM23518; Biaryl Anthranilide Analogue, 1b; TUCHRHOVXUFQLY-UHFFFAOYSA-N; 2-[3-(naphthalen-2-yl)propanamido]benzoic acid; 2-{[3-(2-naphthalenyl)propanoyl]amino}benzoic acid
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 319.4
Logarithm of the Partition Coefficient (xlogp) 4.3
Rotatable Bond Count (rotbonds) 5
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C20H17NO3
IUPAC Name
2-(3-naphthalen-2-ylpropanoylamino)benzoic acid
Canonical SMILES
C1=CC=C2C=C(C=CC2=C1)CCC(=O)NC3=CC=CC=C3C(=O)O
InChI
InChI=1S/C20H17NO3/c22-19(21-18-8-4-3-7-17(18)20(23)24)12-10-14-9-11-15-5-1-2-6-16(15)13-14/h1-9,11,13H,10,12H2,(H,21,22)(H,23,24)
InChIKey
TUCHRHOVXUFQLY-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
11594881
TTD ID
D0M4BZ

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Nicotinic acid receptor (HCAR2) TTWNV8U HCAR2_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Molecular modeling aided design of nicotinic acid receptor GPR109A agonists. Bioorg Med Chem Lett. 2008 Sep 15;18(18):4963-7.